Publications by authors named "Mark Rettenmaier"

Claim this Profile
V
Vaping and Smoking Cessation.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

Subst Use Misuse· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical differences among the PARP inhibitors in the first-line treatment of advanced-stage ovarian carcinoma.
John P Micha, Mark A Rettenmaier, Randy Bohart, Joshua P Gorman, Bram H Goldstein

Expert Rev Anticancer Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin use and ovarian cancer outcomes.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

Expert Rev Anticancer Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical marijuana in the treatment of cancer-associated symptoms.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Oncol Pharm Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Aspirin Use Reduce the Risk for Ovarian Cancer?
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

Cancer Invest· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Oncol Pharm Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to the letter to the editor: a response to Tran and Egilman.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

Arch Gynecol Obstet· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancer.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Robot Surg· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged endocrine therapy in the management of hormone receptor-positive early-stage breast cancer: What is the appropriate duration?
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Obstet Gynaecol Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Gynecol Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talc powder and ovarian cancer: what is the evidence?
John P Micha, Mark A Rettenmaier, Randy Bohart, Bram H Goldstein

Arch Gynecol Obstet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone Therapy and Risk of Breast Cancer: Where Are We Now?
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

J Menopausal Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robotic-Assisted Surgery for the Treatment of Breast and Cervical Cancers.
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein

JSLS· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic viral therapy engenders a clinical response in a recurrent ovarian cancer patient.
John Micha, Mark Rettenmaier, Peter Giuliano, Randy Bohart, Bram Goldstein

Anticancer Drugs· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confounding variables in survival analysis: A response to the letter to the editor.
Mark A Rettenmaier, Bram H Goldstein

Eur J Obstet Gynecol Reprod Biol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy with hyperthermic intraperitoneal chemotherapy in the treatment of advanced stage ovarian carcinoma.
Mark A Rettenmaier, John P Micha, Randy Bohart, Bram H Goldstein

Eur J Obstet Gynecol Reprod Biol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective, Observational Trial Assessing the Efficacy of Abdominal Compression in Reducing Laparoscopic-Induced Shoulder Pain.
Mark A Rettenmaier, John P Micha, Katrina L Lopez, Amber M Wilcox, Bram H Goldstein

Surg Innov· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation hyperthermic intraperitoneal chemotherapy for the treatment of advanced stage ovarian carcinoma: a 3 year experience.
Alberto A Mendivil, Mark A Rettenmaier, Lisa N Abaid, John V Brown, Kristina M Mori

Cancer Chemother Pharmacol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: #00279 "Dramatically reduced incidence of vaginal cuff dehiscence in gynecologic patients undergoing endoscopic closure with barbed sutures: A retrospective cohort study".
Mark A Rettenmaier, Bram H Goldstein

Int J Surg· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of total parenteral nutrition on postoperative recovery in patients treated for advanced stage ovarian cancer.
Alberto A Mendivil, Mark A Rettenmaier, Lisa N Abaid, John V Brown, Kristina M Mori

Arch Gynecol Obstet· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower-extremity lymphedema following management for endometrial and cervical cancer.
Alberto A Mendivil, Mark A Rettenmaier, Lisa N Abaid, John V Brown, John P Micha

Surg Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of open surgery, robotic-assisted surgery and conventional laparoscopic surgery in the treatment of morbidly obese endometrial cancer patients.
Alberto A Mendivil, Mark A Rettenmaier, Lisa N Abaid, John V Brown, John P Micha

JSLS· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience.
Alberto A Mendivil, Mark A Rettenmaier, Lisa N Abaid, John V Brown, John P Micha

Surg Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Controlled Pilot Study Comparing the Impact of Aprepitant and Fosaprepitant on Chemotherapy Induced Nausea and Vomiting in Patients Treated for Gynecologic Cancer.
John P Micha, Mark A Rettenmaier, John V Brown, Alberto Mendivil, Lisa N Abaid

Int J Gynecol Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dramatically reduced incidence of vaginal cuff dehiscence in gynecologic patients undergoing endoscopic closure with barbed sutures: A retrospective cohort study.
Mark A Rettenmaier, Lisa N Abaid, John V Brown, Alberto A Mendivil, Katrina L Lopez

Int J Surg· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis